Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals

Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET

Lars Farde, Håkan Hall, E. Ehrin et al. · Science · 1986 · 842 citations

Medicine, Neuroscience, Pharmacology +16

Specific in vitro and in vivo binding of 3H-raclopride a potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

Christer Köhler, Håkan Hall, Sven Ove Ögren et al. · Biochemical Pharmacology · 1985 · 506 citations

Medicine, Neuroscience, Pharmacology +12

Positron emission tomographic imaging of the dopamine transporter with ¹¹C‐WIN 35,428 reveals marked declines in mild Parkinson's disease

J. James Frost, Annemie Rosier, Stephen G. Reich et al. · Annals of Neurology · 1993 · 322 citations

Medicine, Neurology, Neuroscience +17

Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11C]WAY-100635

Victor W. Pike, Julie A. McCarron, Adriaan A. Lammertsma et al. · European Journal of Pharmacology · 1996 · 225 citations

Medicine, Neuroscience, Pharmacology +9

The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes

H. Gozlan, Stéphanie Thibault, Anne‐Marie Laporte et al. · European Journal of Pharmacology Molecular Pharmacology · 1995 · 181 citations

Life Sciences, Neuroscience, Pharmacology +16